AERIE PHARMACEUTICALS INC — Form D

AERIE PHARMACEUTICALS INC of Bedminster, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-01. The offering totals $41.4M, of which $41.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
David EpsteinDirectorSan Francisco, CA
Thomas van HaarlemDirectorBridgewater, NJ
Mitchell deLongExecutive OfficerBridgewater, NJ
David EpsteinExecutive OfficerSan Francisco, CA
Thomas van HaarlemExecutive OfficerBridgewater, NJ
James MazzoDirectorEVEN YEHUDA, L3
Gerald CagleDirectorFort Worth, TX
Brian LevyExecutive OfficerSyosset, NY
Anand MehraDirectorWayne, PA
David GryskaDirectorDallas, TX
Richard RubinoExecutive OfficerBoston, MA
David MackDirectorCranbury, NJ
Dennis HennerDirectorBurlingame, CA
Geoffrey DuykDirectorEMERYVILLE, CA
VICENTE ANIDODirectorBEDMINSTER, NJ
VICENTE ANIDOExecutive OfficerBEDMINSTER, NJ
MURRAY GOLDBERGDirectorBEDMINSTER, NJ
CASEY KOPCZYNSKIExecutive OfficerBEDMINSTER, NJ
THOMAS MITROExecutive OfficerBEDMINSTER, NJ
JANET CONWAYDirectorBEDMINSTER, NJ
MURRAY J GOLDBERGDirectorBEDMINSTER, NJ
THOMAS J MITROExecutive OfficerBEDMINSTER, NJ
RICHARD J RUBINOExecutive OfficerBEDMINSTER, NJ
DAVID J EPSTEINDirectorBEDMINSTER, NJ
DENNIS J HENNERDirectorBEDMINSTER, NJ

Other filings by this issuer (4)

FiledFormOfferingSold
2014-09-23D$125.0M$125.0M
2013-08-29D/A$18.0M$15.0M
2012-12-19D$15.0M$3.0M
2010-09-01D$5.3M$5.3M

More